VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $469,373,000 | +7.1% | 20,824 | -30.2% | 0.01% | +150.0% |
| Q1 2017 | $438,115,000 | -76.9% | 29,824 | -58.7% | 0.00% | -81.0% |
| Q1 2016 | $1,900,464,000 | +374.6% | 72,261 | +1734.5% | 0.02% | +425.0% |
| Q4 2015 | $400,399,000 | -99.6% | 3,939 | -99.4% | 0.00% | -99.7% |
| Q3 2015 | $108,642,161,000 | -29.7% | 609,049 | -12.5% | 1.20% | -20.9% |
| Q2 2015 | $154,626,175,000 | +5.3% | 696,044 | -5.8% | 1.51% | +18.5% |
| Q1 2015 | $146,869,543,000 | +8.3% | 738,662 | -22.0% | 1.28% | -1.1% |
| Q4 2014 | $135,605,169,000 | -0.4% | 947,559 | -8.7% | 1.29% | -2.8% |
| Q3 2014 | $136,160,540,000 | +12.3% | 1,037,809 | +7.9% | 1.33% | +13.6% |
| Q2 2014 | $121,272,073,000 | +26.2% | 961,561 | +31.9% | 1.17% | +14.2% |
| Q1 2014 | $96,084,691,000 | +7.3% | 728,853 | -4.5% | 1.02% | -0.2% |
| Q4 2013 | $89,572,091,000 | +11.4% | 762,965 | -1.0% | 1.02% | +2.0% |
| Q3 2013 | $80,430,730,000 | +63.5% | 770,926 | -4.8% | 1.00% | +33.6% |
| Q2 2013 | $49,189,781,000 | – | 809,737 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |